Clinical Trials Browser

Phase 2 × Completed × Vinorelbine × Clear all

NCT04296162 2026-05-26

ORCHID

Phase 2 Completed

Breast Neoplasms

NCT03482362 2025-08-03

EORTC1616

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT06533722 2025-06-10

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

Phase 2 Completed

HER2-negative Metastatic Breast Cancer

NCT03242616 2025-04-17

PemVin vs Vin in Previously Treated Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT03442673 2025-03-28

MOCCCA

Phase 2 Completed

Multiple Myeloma

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT03443128 2025-02-13

Vinorelbine for Recurrent ALCL-2017

Phase 2 Completed

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT00309998 2024-10-29

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03839823 2024-10-09

RIGHT Choice

Phase 2 Completed

222 enrolled 17 charts

Breast Neoplasms

NCT03887130 2024-04-30

Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer

Phase 2 Completed

152 enrolled 14 charts

Breast Neoplasms

NCT03321981 2024-03-07

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

Phase 2 Completed

105 enrolled 23 charts

Lethal Congenital Contracture Syndrome 2

NCT02954055 2024-02-26

METEORA-II

Phase 2 Completed

140 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02709720 2024-01-11

NORA

Phase 2 Completed

68 enrolled 21 charts

Lung Neoplasms

NCT00574496 2023-09-28

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Phase 2 Completed

25 enrolled 10 charts

Hodgkin Disease, Lymphoma, Recurrence

NCT00602797 2023-09-26

Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

20 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00005847 2023-06-22

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT03345810 2023-06-15

DURATION

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03397953 2022-07-26

Vinorelbine for Recurrent ACLC

Phase 2 Completed

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT00887783 2022-05-17

NARLAL

Phase 2 Completed

117 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT03801304 2022-05-12

VinMetAtezo

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT03254654 2022-04-20

Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer

Phase 2 Completed

Advanced Triple-Negative Breast Cancer

NCT04903652 2022-04-07

Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer

Phase 2 Completed

HER2-positive Advanced Breast Cancer

NCT02139904 2021-10-12

VIM

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma

NCT01835236 2021-03-30

Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00381940 2021-03-24

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Phase 2 Completed

26 enrolled 14 charts

Hodgkin Disease, Recurrence

NCT02610140 2020-11-04

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Phase 2 Completed

248 enrolled 23 charts

Other solid neoplasmThoracic

Mesothelioma

NCT00006682 2020-08-14

Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00003963 2020-08-03

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation

Phase 2 Completed

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02362958 2020-07-15

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Phase 2 Completed

HER2 Positive Breast Cancer

NCT03652857 2020-02-17

Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer

Phase 2 Completed

Advanced Non Small Cell Lung Cancer

NCT00003400 2019-11-04

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT02628613 2019-11-01

Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations

Phase 2 Completed

Breast Neoplasms

NCT00349089 2019-09-19

Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT03007992 2019-08-12

VinoMetro

Phase 2 Completed

Breast Neoplasms

NCT00003259 2019-06-26

Vinorelbine in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT01271725 2019-06-17

LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures

Phase 2 Completed

74 enrolled 16 charts

Breast Neoplasms

NCT01497860 2019-05-20

Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas

Phase 2 Completed

13 enrolled 4 charts

Glioma, Recurrence

NCT02176369 2019-04-22

ONC-MANILA12

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00148681 2019-01-15

Preoperative Herceptin and Navelbine for Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01305941 2018-12-17

A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases

Phase 2 Completed

32 enrolled 19 charts

Brain Neoplasms, Breast Neoplasms

NCT00266110 2018-09-12

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 2 Completed

17 enrolled 9 charts

Breast Neoplasms

NCT01443078 2018-08-09

Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)

Phase 2 Completed

42 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00256282 2018-05-03

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Phase 2 Completed

52 enrolled 8 charts

Melanoma

NCT01029678 2018-05-03

RACCOSA

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02791373 2018-04-03

ViGeM

Phase 2 Completed

Amyloidosis, Multiple Myeloma

NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Phase 2 Completed

50 enrolled 13 charts

Breast Neoplasms

NCT01520103 2017-08-09

VicTORia

Phase 2 Completed

Breast Neoplasms

NCT00388349 2017-06-14

Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

Phase 2 Completed

146 enrolled 12 charts

Hodgkin Disease, Lymphoma

NCT01013740 2017-05-31

VITAL

Phase 2 Completed

112 enrolled 15 charts

Breast Neoplasms, Neoplasms